In November’s volume of The Lancet Neurology, the MS21 initiative was delighted to be mentioned alongside a number of like-minded and important initiatives all advocating the importance of the patient voice in MS care. The Editorial, titled ‘Patient-reported outcomes in the spotlight’ follows the recent launch of the European Charcot Foundation’s initiative ‘PROMS’, and discusses the importance of patients’ perspectives on their disease status and maintaining their health in the longer term, as well as recognizing their views as an essential part of research studies and neurological practice. If you haven’t seen it yet, read the full editorial here: www.thelancet.com/journals/laneur/article/PIIS1474-4422(19)30357-6/fulltext